# A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia

> **NCT05189639** · — · RECRUITING · sponsor: **Pfizer** · enrollment: 165 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05189639
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-05
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05189639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05189639, "A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05189639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*